je.st
news
Tag: biocryst
Noble Financial Reaffirms "Buy" Rating for BioCryst Pharmaceuticals, Inc.
2016-02-28 04:00:20| Biotech - Topix.net
's stock had its "buy" rating restated by Noble Financial in a research report issued to clients and investors on Friday, Analyst Ratings Network.com reports. They presently have a $8.00 target price on the biotechnology company's stock.
Tags: inc
buy
rating
financial
BioCryst Pharmaceuticals Downgraded to Underperform at Bank of America
2015-11-16 05:33:57| Biotech - Topix.net
They presently have a $10.00 price target on the biotechnology company's stock, down from their previous price target of $12.00. Bank of America's price objective would indicate a potential upside of 3.95% from the stock's previous close.
Tags: america
bank
pharmaceuticals
downgraded
BioCryst Pharmaceuticals Expected to Post FY2019 Earnings of
2015-11-08 04:29:07| Biotech - Topix.net
Research analysts at FBR & Co. lifted their FY2019 earnings per share estimates for shares of BioCryst Pharmaceuticals in a note issued to investors on Thursday, according to Zacks .
Tags: post
expected
earnings
pharmaceuticals
BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group
2015-10-18 09:44:56| Biotech - Topix.net
The firm presently has a "hold" rating on the biotechnology company's stock. Jefferies Group's price objective would indicate a potential upside of 13.12% from the stock's previous close.
Tags: price
group
target
lowered
BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430...
2014-12-15 18:43:01| Biotech - Topix.net
BioCryst Pharmaceuticals, Inc. today announced the dosing of the first subject in a randomized, placebo-controlled Phase 1 clinical trial to evaluate intramuscular administration of BCX4430 in healthy volunteers. BCX4430 is being developed as a potential treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease.